Literature DB >> 15511716

The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.

E C Johnstone1, P Yudkin, S E Griffiths, A Fuller, M Murphy, R Walton.   

Abstract

A single nucleotide polymorphism (SNP) in the Taq1A site near the DRD2 gene has been associated in several studies with smoking behaviour. We genotyped 732 current smokers (241 low, one to nine cigarettes a day, 250 mid, 10-19 cigarettes, 241 high, 20+cigarettes) and 243 never-smokers at this site (C32806T), to test for effects on smoking initiation and amount of tobacco consumed. No significant association between minor allele frequency and smoking status was detected. Multiple regression analysis including DRD2 genotype, sex, age and alcohol consumption as predictors showed that level of cigarette consumption was associated with sex (p=0.003) and age (p=0.002) but not with alcohol consumption (p=0.25) or DRD2 genotype (p=0.76).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15511716     DOI: 10.1080/13556210412331292226

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  11 in total

Review 1.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

2.  CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.

Authors:  Paulo Roberto Xavier Tomaz; Juliana Rocha Santos; Jaqueline Scholz Issa; Tânia Ogawa Abe; Patrícia Viviane Gaya; José Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Júnior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2015-07-08       Impact factor: 2.953

Review 3.  Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Authors:  Sean P David; Elaine C Johnstone; Michael Churchman; Paul Aveyard; Michael F G Murphy; Marcus R Munafò
Journal:  Nicotine Tob Res       Date:  2011-01-25       Impact factor: 4.244

4.  TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood.

Authors:  Francesca Ducci; Marika Kaakinen; Anneli Pouta; Anna-Liisa Hartikainen; Juha Veijola; Matti Isohanni; Pimphen Charoen; Lachlan Coin; Clive Hoggart; Jesper Ekelund; Leena Peltonen; Nelson Freimer; Paul Elliott; Gunter Schumann; Marjo-Riitta Järvelin
Journal:  Biol Psychiatry       Date:  2010-12-17       Impact factor: 13.382

Review 5.  The genetics of nicotine dependence: relationship to pancreatic cancer.

Authors:  Stewart L MacLeod; Parimal Chowdhury
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 6.  Genetics of dopamine receptors and drug addiction.

Authors:  Philip Gorwood; Yann Le Strat; Nicolas Ramoz; Caroline Dubertret; Jean-Marie Moalic; Michel Simonneau
Journal:  Hum Genet       Date:  2012-02-17       Impact factor: 4.132

7.  Identification of pharmacogenetic markers in smoking cessation therapy.

Authors:  Daniel F Heitjan; Mengye Guo; Riju Ray; E Paul Wileyto; Leonard H Epstein; Caryn Lerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

8.  D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes.

Authors:  Neal D Barnard; Ernest P Noble; Terry Ritchie; Joshua Cohen; David J A Jenkins; Gabrielle Turner-McGrievy; Lise Gloede; Amber A Green; Hope Ferdowsian
Journal:  Nutrition       Date:  2008-10-02       Impact factor: 4.008

Review 9.  Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.

Authors:  Margaret Mroziewicz; Rachel F Tyndale
Journal:  Addict Sci Clin Pract       Date:  2010-12

10.  Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Authors:  Alicja Sieminska; Krzysztof Buczkowski; Ewa Jassem; Marek Niedoszytko; Ewa Tkacz
Journal:  BMC Med Genet       Date:  2009-09-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.